CONCLUSIONS: This single case report showed an improvement of the scores of each test used after 3 months of treatment. Double-blind clinical trials are warranted to test the efficacy of bumetanide in FRX.
Mesh : Bumetanide / adverse effects therapeutic use Child Child Development Disorders, Pervasive / complications Diuretics / adverse effects therapeutic use Fragile X Syndrome / complications drug therapy Humans Hypokalemia / chemically induced Male
来 源:
DOI:10.1111/apa.12235
PDF(Sci-hub)